← Leaderboards
Tomas Maira-Litran
Brigham And Women'S Hospital
$1,043,055
Attributed
$1,043,055
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $288.5K · FY2008–16$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,043,055 · 2
By mechanism
R41$576,805 · 1
R21$466,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Joshua A Boyce$54,050,346
- Charles Nicholas Serhan$33,627,216
- Gerald B Pier$23,267,480
- Laura Elizabeth Fredenburgh$4,191,382
- Tanya Maria Laidlaw$5,208,119
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroInfectionPathogenResistanceAntibioticsGenesGrowthIn VivoBacteriaAnimalsBinding (Molecular Function)Anthrax DiseaseAnti-Bacterial AgentsBaseBacterial InfectionsAcinetobacter BaumanniiBiochemicalAnimal ModelBacillus (Bacterium)Bacillus AnthracisBacteremiaAnabolismAcyl GroupAssay Development
Grant awards (4)
Lipoprotein synthesis inhibitors for multi-drug resistant Gram-negative therapy$288,311
R41 · FY2016 · AI · contact PI
Lipoprotein synthesis inhibitors for multi-drug resistant Gram-negative therapy$288,494
R41 · FY2015 · AI · contact PI
Multi-componet Vaccine for Staphylcoccus epidermidis$211,250
R21 · FY2009 · AI · contact PI
Multi-componet Vaccine for Staphylcoccus epidermidis$255,000
R21 · FY2008 · AI · contact PI